Table 1.

Basic clinicopathological characteristics of the analyzed NSCLC cohort

Clinicopathological Variables		CD117		p-value	CD5		p-value	CD117/CD5		p-value
		positive	negative		positive	negative		positive	negative
Mean age at surgery	63 years	63 years	63 years	p = 0.79	62 years	63 years	p = 0.13	61 years	63 years	p = 0.25
Patient gender
Male	1016 (69.3 %)	89	921	p = 0.03	76	910	p < 0.01	14	852	p < 0.01
Female	448 (30.5 %)	56	390		57	383		10	356
Histology
Adenocarcinoma	711 (48.5 %)	97	611	p < 0.01	123	564	p < 0.01	26	685	p < 0.01
Squamous Cell Carcinoma	586 (40.0 %)	34	548		0	575		0	586
Adenosquamous Carcinoma	55 (3.8 %)	5	49		4	50		1	54
Large Cell Carcinoma	71 (4.8 %)	8	63		3	67		1	70
Pleomorphic Carcinoma	42 (2.9 %)	1	41		3	38		0	42
TNM-Classification
pT1a	125 (8.5 %)	21	102	p = 0.07	16	103	p = 0.02	4	121	p = 0.10
pT1b	158 (10.8 %)	19	138		20	135		5	153
pT2a	641 (43.8 %)	62	578		64	554		15	626
pT2b	245 (16.7 %)	22	221		16	228		2	243
pT3	248 (16.9 %)	17	230		13	230		1	247
pT4	48 (3.3 %)	4	43		4	44		1	47
pN0	755 (51.5 %)	83	667	p = 0.16	80	651	p = 0.03	16	739	p = 0.57
pN1	353 (24.0 %)	27	324		15	330		2	351
pN2	351 (23.9 %)	35	315		38	309		10	341
pN3	6 (0.4 %)	0	6		0	4		0	6
pM0	1426 (97.3 %)	143	1275	p = 0.42	129	1261	p = 0.77	27	1399	p = 0.53
pM1a	6 (0.4 %)	0	6		2	4		1	5
pM1b	33 (2.3 %)	2	31		2	29		0	33
Clinical stage
I A	190 (12.9 %)	25	162	p = 0.32	25	156	p = 0.05	6	184	p = 0.48
IB	344 (23.5 %)	32	312		38	293		7	337
IIA	277 (18.9 %)	28	248		15	259		3	274
IIB	165 (11.3 %)	18	145		11	152		1	164
IIIA	422 (28.8 %)	40	380		39	376		11	411
IIIB	29 (1.9 %)	0	29		2	25		0	29
IV	38 (2.6 %)	2	36		3	33		0	38